Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cara Therapeutics Stock Price (Quote) NASDAQ:CARA
$13.16 ( -1.35% ) Friday, 15th Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $13.08 | $16.25 | Friday, 15th Oct 2021 CARA stock ended at $13.16. This is 1.35% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 3.44% from a day low at $13.08 to a day high of $13.53. |
| 90 days | $11.22 | $18.25 | |
| 52 weeks | $11.22 | $29.65 |
Historical Cara Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-15 | $13.45 | $13.53 | $13.08 | $13.16 | 380 063 |
| 2021-10-14 | $13.40 | $13.73 | $13.31 | $13.34 | 553 410 |
| 2021-10-13 | $13.73 | $13.80 | $13.29 | $13.35 | 434 019 |
| 2021-10-12 | $13.96 | $14.05 | $13.72 | $13.74 | 293 081 |
| 2021-10-11 | $14.15 | $14.30 | $13.94 | $13.97 | 480 635 |
| 2021-10-08 | $14.20 | $14.27 | $14.01 | $14.18 | 247 487 |
| 2021-10-07 | $13.85 | $14.17 | $13.75 | $14.15 | 537 965 |
| 2021-10-06 | $13.99 | $14.01 | $13.64 | $13.75 | 471 734 |
| 2021-10-05 | $14.36 | $14.60 | $14.01 | $14.19 | 642 579 |
| 2021-10-04 | $15.17 | $15.17 | $14.40 | $14.44 | 483 960 |
| 2021-10-01 | $15.40 | $15.48 | $14.83 | $15.25 | 431 522 |
| 2021-09-30 | $15.43 | $15.71 | $15.27 | $15.45 | 288 204 |
| 2021-09-29 | $15.47 | $15.61 | $15.23 | $15.36 | 298 607 |
| 2021-09-28 | $16.00 | $16.01 | $15.35 | $15.38 | 352 666 |
| 2021-09-27 | $15.92 | $16.25 | $15.81 | $16.04 | 383 932 |
| 2021-09-24 | $15.82 | $16.13 | $15.79 | $15.93 | 520 614 |
| 2021-09-23 | $15.66 | $15.91 | $15.51 | $15.85 | 430 924 |
| 2021-09-22 | $15.50 | $15.70 | $15.28 | $15.63 | 427 095 |
| 2021-09-21 | $15.45 | $15.75 | $15.27 | $15.60 | 645 255 |
| 2021-09-20 | $14.84 | $15.36 | $14.81 | $15.31 | 716 840 |
| 2021-09-17 | $14.97 | $15.30 | $14.71 | $15.25 | 1 678 011 |
| 2021-09-16 | $14.65 | $14.98 | $14.30 | $14.93 | 631 116 |
| 2021-09-15 | $14.57 | $15.04 | $14.55 | $14.77 | 598 540 |
| 2021-09-14 | $15.00 | $15.00 | $14.49 | $14.63 | 569 784 |
| 2021-09-13 | $15.27 | $15.29 | $14.64 | $14.90 | 710 684 |
| 2021-09-10 | $15.60 | $15.80 | $15.23 | $15.27 | 576 864 |
| 2021-09-09 | $15.52 | $15.83 | $15.32 | $15.56 | 670 627 |
| 2021-09-08 | $15.55 | $15.76 | $15.25 | $15.54 | 793 528 |
| 2021-09-07 | $15.25 | $15.85 | $15.16 | $15.62 | 798 476 |
| 2021-09-03 | $15.64 | $15.74 | $15.10 | $15.24 | 1 015 688 |
| 2021-09-02 | $16.00 | $16.28 | $15.59 | $15.74 | 1 233 466 |
| 2021-09-01 | $15.89 | $16.08 | $15.57 | $16.06 | 1 233 218 |
| 2021-08-31 | $14.73 | $15.83 | $14.66 | $15.78 | 1 735 281 |
| 2021-08-30 | $14.17 | $15.07 | $14.15 | $14.83 | 1 822 971 |
| 2021-08-27 | $13.62 | $14.89 | $13.60 | $14.58 | 2 875 840 |
| 2021-08-26 | $14.16 | $14.33 | $13.40 | $13.66 | 2 317 102 |
| 2021-08-25 | $14.34 | $14.63 | $13.64 | $14.27 | 5 443 868 |
| 2021-08-24 | $17.29 | $18.25 | $14.53 | $14.88 | 37 301 539 |
| 2021-08-23 | $14.11 | $14.64 | $13.55 | $14.28 | 4 476 311 |
| 2021-08-20 | $12.45 | $13.90 | $12.33 | $13.70 | 1 870 596 |
| 2021-08-19 | $12.90 | $13.29 | $12.36 | $12.41 | 840 864 |
| 2021-08-18 | $13.09 | $13.36 | $12.77 | $13.07 | 731 959 |
| 2021-08-17 | $12.60 | $12.98 | $12.33 | $12.72 | 682 292 |
| 2021-08-16 | $14.12 | $14.12 | $12.50 | $12.54 | 1 252 133 |
| 2021-08-13 | $13.52 | $14.02 | $13.18 | $13.85 | 1 208 387 |
| 2021-08-12 | $13.10 | $13.39 | $12.78 | $13.33 | 596 799 |
| 2021-08-11 | $13.44 | $13.47 | $12.91 | $13.12 | 799 621 |
| 2021-08-10 | $12.24 | $13.59 | $12.10 | $12.99 | 1 108 464 |
| 2021-08-09 | $12.97 | $13.18 | $12.51 | $12.51 | 909 353 |
| 2021-08-06 | $12.68 | $12.85 | $12.04 | $12.78 | 971 085 |
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system. Its lead product candidate includes I.V. CR845, which is in Phase III clinical trials for the treatment acute postop... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
